Table 3.
MACE incidence rate analysis based on age, gender, hDM, and hHTN by multivariable approach in mid‐term
| Patients (n = 1799) | HR (95% CI) |
Adjusted P value |
||||
|---|---|---|---|---|---|---|
|
MACE (n = 34) |
no MACE (n = 1765) | HR | L | U | ||
| Age at enrollment PCI (y) | 58.38 ± 10.91 | 60.18 ± 11.25 | 0.987 | 0.956 | 1.018 | .370 |
| Gender (Male) | 21(61.76) | 1080(61.18) | 1.052 | 0.513 | 2.161 | .885 |
| no hDM no hHTN | 4(11.76) | 601(34.05) | 1 | ‐ | ‐ | ‐ |
| hDM | 3(8.82) | 173(9.80) | 2.783 | 0.621 | 12.466 | .181 |
| hHTN | 9(26.47) | 639(36.20) | 2.684 | 0.811 | 8.885 | .106 |
| hDM + hHTN | 17(50.0) | 353(20.0) | 9.375 | 3.053 | 28.785 | <.001 |
Data were presented as mean ± sd for age and number (%) for other variables.
Male is the reference for gender and no hDM no hHTN group is the reference with regard to hDM and hHTN status.
Abbreviations: CI, confidence interval; HR, hazard ratio; L, lower bound; U, upper bound.
Bold values imply statistical significance.